Affiliation:
1. Center for Disease Dynamics, Economics & Policy, Washington, DC, USA; Princeton Environmental Institute, Princeton, NJ, USA; Public Health Foundation of India, New Delhi, India.
Abstract
Antibiotic effectiveness is a natural societal resource that is diminished by antibiotic use. As with other such assets, keeping it available requires both conservation and innovation. Conservation encompasses making the best use of current antibiotic effectiveness by reducing demand through vaccination, infection control, diagnostics, public education, incentives for clinicians to prescribe fewer antibiotics, and restrictions on access to newer, last-resort antibiotics. Innovation includes improving the efficacy of current drugs and replenishing effectiveness by developing new drugs. In this paper, I assess the relative benefits and costs of these two approaches to maintaining our ability to treat infections.
Publisher
American Association for the Advancement of Science (AAAS)
Reference35 articles.
1. Antibiotic resistance—the need for global solutions
2. World Health Organization Baseline Report on Globally Sexually Transmitted Infection Surveillance 2012 (World Health Organization Geneva Switzerland 2013); http://apps.who.int/iris/bitstream/10665/85376/1/9789241505895_eng.pdf.
3. Global Spread of Carbapenemase-producingEnterobacteriaceae
4. Economics of Antibiotic Resistance: A Theory of Optimal Use
5. R. Laxminarayan A. Malani D. Howard D. L. Smith Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance (Resources for the Future Washington DC 2007).
Cited by
136 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献